| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 07/27/2011 | EP2013213B1 Constrained compounds as cgrp-receptor antagonists |
| 07/27/2011 | EP1912995B1 Macrocylic inhibitors of hepatitis c virus |
| 07/27/2011 | EP1797096B1 Pyrazolopyrimidines as inhibitors of protein kinase b (akt) |
| 07/27/2011 | EP1638568B1 Indole, azaindole and related heterocyclic n-substituted piperazine derivatives |
| 07/27/2011 | CN102137854A 4-(pyridin-4-yl)-1H-[1,3,5]triazin-2-one derivatives as GSK3-beta inhibitors for the treatment of neurodegenerative diseases |
| 07/27/2011 | CN102134244A Medical photosensitizer and preparation method thereof |
| 07/27/2011 | CN102134243A Bicyclic amino pyrazole derivatives with anti-tumor activity |
| 07/27/2011 | CN102134242A Novel compounds for quickly treating impotence with long-lasting action |
| 07/27/2011 | CN102134213A 5-(alpha-methoxylbenzyl)pyrrole compound as well as preparation method and application thereof |
| 07/27/2011 | CN101538268B Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
| 07/26/2011 | US7985753 Substituted pyrazolo[1,5-A]pyrimidines as metabotropic glutamate receptor modulators |
| 07/26/2011 | CA2496308C Alkyl-substituted pyrazolopyrimidines |
| 07/26/2011 | CA2487976C Calcitonin gene related peptide receptor antagonists |
| 07/21/2011 | WO2011088045A1 Aurora kinase compounds and methods of their use |
| 07/21/2011 | WO2011086931A1 Three-dimensional structure and manufacturing method for same |
| 07/21/2011 | WO2011086099A1 Novel substituted triazole derivatives as gamma secretase modulators |
| 07/21/2011 | WO2011086098A1 Novel substituted bicyclic triazole derivatives as gamma secretase modulators |
| 07/21/2011 | WO2011086053A1 Tricyclic heterocyclic compounds, compositions and methods of use thereof |
| 07/21/2011 | WO2011085544A1 Compounds which effecttively remove tumor or cancer cell |
| 07/21/2011 | WO2011085473A1 Treating cancer with statins and compounds having dipyridamole activity |
| 07/21/2011 | WO2011025932A3 Preparation of sitagliptin and salts thereof |
| 07/21/2011 | WO2010091808A8 Fused pyrimidines |
| 07/21/2011 | US20110178301 Heterocyclical chromophore architectures |
| 07/21/2011 | US20110178294 Novel carboxylic acid derivatives, their preparation and use |
| 07/21/2011 | US20110178107 Hcv protease inhibitors |
| 07/21/2011 | US20110178106 5-quinolinone and imidazopyridine compounds and use thereof |
| 07/21/2011 | US20110178078 Substituted 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines, serotonin 5-ht6 receptor antagonists and methods for the production and use thereof |
| 07/21/2011 | US20110178075 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 07/21/2011 | US20110178069 Inhibitors of interleukin-1 beta converting enzyme |
| 07/21/2011 | US20110178067 Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases |
| 07/21/2011 | US20110178065 Novel cyp17 inhibitors |
| 07/21/2011 | US20110178063 Benzpyrazol derivatives as inhibitors of pi3 kinases |
| 07/21/2011 | US20110178055 Dual nk1/nk3 receptor antagonists |
| 07/21/2011 | US20110178031 Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid |
| 07/21/2011 | US20110177011 Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of bruton's tyrosine kinase by such compounds |
| 07/21/2011 | US20110177007 Dithienopyrrole Dyes for Imaging and Therapy |
| 07/21/2011 | US20110177006 Dithienofuran Dyes for Imaging and Therapy |
| 07/21/2011 | CA2784769A1 Novel substituted triazole derivatives as gamma secretase modulators |
| 07/21/2011 | CA2784765A1 Novel substituted bicyclic triazole derivatives as gamma secretase modulators |
| 07/21/2011 | CA2781578A1 Tricyclic heterocyclic compounds, compositions and methods of use thereof |
| 07/20/2011 | EP2345655A1 A process for racemisation of 6-(5-chloropyridin-2-yl)-7-(4-methyl-1-piperazinyl)carbonyloxy-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine |
| 07/20/2011 | EP2345654A1 Eszopiclone particles and a process for their preparation |
| 07/20/2011 | EP2345411A1 Heterocyclic aspartyl protease inhibitors, preparation and use thereof |
| 07/20/2011 | EP2344505A2 Indole and indoline derivatives and methods of use thereof |
| 07/20/2011 | EP2344504A1 Pyrrolotriazine kinase inhibitors |
| 07/20/2011 | EP2344503A2 5-azaindole bisphosphonates |
| 07/20/2011 | EP2344502A2 Pyrimidinyl pyridone inhibitors of jnk |
| 07/20/2011 | EP2344495A1 Tricyclic oxazolidinone antibiotic compounds |
| 07/20/2011 | EP2247595B1 Pyrrolopyrazine kinase inhibitors |
| 07/20/2011 | EP2049544B9 Purinone derivatives as hm74a agonists |
| 07/20/2011 | CN1930137B Novel benzothiazepine and benzothiepine compounds |
| 07/20/2011 | CN1898245B Process for the preparation of triazolopyrimidines |
| 07/20/2011 | CN102131813A Biocatalytic processes for preparation of substantially stereomerically pure fused bicyclic proline compounds |
| 07/20/2011 | CN102131812A Pyrrolo[2,3-d]pyrimidine compounds |
| 07/20/2011 | CN102131811A Oxazolidinone derivative having fused ring |
| 07/20/2011 | CN102131810A Diketone fused azolopiperidines and azolopiperazines as anti-hiv agents |
| 07/20/2011 | CN102131788A Compounds and compositions as protein kinase inhibitors |
| 07/20/2011 | CN102131581A Catalyst for degrading lignin, catalyst for degrading aromatic hydrocarbon, and porphyrin |
| 07/20/2011 | CN102127096A Triazole pyridine and triazole pyrazine compound and composition and application thereof |
| 07/20/2011 | CN102127085A Use of pyrimido[5,4-g]pteridines as shading component in color filter colorant compositions |
| 07/20/2011 | CN102127084A Alkoxy bicyclic guanidine as well as preparation method and application thereof |
| 07/20/2011 | CN102127083A Alkane group bicyclo-guanidine, preparation method and application of alkane group bicyclo-guanidine |
| 07/20/2011 | CN102127082A Hydroxyl hydrocarbyl bicyclic guanidine and preparation method and use thereof |
| 07/20/2011 | CN102125549A Dihydroporphin photosensitizer as well as preparation method and application thereof |
| 07/20/2011 | CN101591338B Method for synthesizing indiplon |
| 07/20/2011 | CN101305007B Pyrazolo[4,3-d]pyrimidin-5-yl)derivative used as PDE5 inhibitors |
| 07/20/2011 | CN101248077B P38 map kinase inhibitors and methods for using the same |
| 07/20/2011 | CN101177427B Compound polycrystalline type alpha and solvate for hypnotism, preparation method and combination including the same |
| 07/20/2011 | CN101054380B Pyrazolopyrimidine derivative used as cell cycle dependency protein kinase inhibitor |
| 07/19/2011 | US7982037 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3 |
| 07/19/2011 | US7982033 Pyrrolotriazine kinase inhibitors |
| 07/19/2011 | US7981903 2-[2-{phenylamino}-1H-pyrrolo[2,3-D]pyrimidin-4-yl)amino] benzamide derivatives as IGF-1R inhibitors for the treatment of cancer |
| 07/19/2011 | US7981902 Substituted pyrrolo[2,3-d]pyrimidines for selectively targeting tumor cells with FR type receptors |
| 07/19/2011 | US7981889 e.g. 4-[5-(Piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; multiple sclerosis |
| 07/19/2011 | US7981881 Fused heterocyclic compounds and use thereof |
| 07/19/2011 | US7981204 Porphyrazine coloring matter and ink composition containing the same |
| 07/19/2011 | CA2465272C Separation of regioisomers of metal phthalocyanines |
| 07/19/2011 | CA2344169C Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 07/19/2011 | CA2237590C Cyclic and heterocyclic n-substituted .alpha.-iminohydroxamic and -carboxylic acids |
| 07/14/2011 | WO2011085170A1 Fungicidal heterocyclic compounds |
| 07/14/2011 | WO2011084642A1 Compound suitable for the treatment of synucleopathies |
| 07/14/2011 | WO2011084434A2 Aza-ring fused indole and indoline derivatives |
| 07/14/2011 | WO2011084433A2 Aza-bridged ring-fused indoles and indolines |
| 07/14/2011 | WO2011083316A1 Benzazepine derivatives for the treatment of central nervous system disorders |
| 07/14/2011 | US20110173726 Pyrazole Compounds for Controlling Invertebrate Pests |
| 07/14/2011 | US20110172424 New crystalline forms of pemetrexed diacid, and preparations thereof |
| 07/14/2011 | US20110172422 Methods of Making Pharmacokinetically Improved Compounds Comprising Functional Residues or Groups and Pharmaceutical Compositions Comprising Said Compounds |
| 07/14/2011 | US20110172255 Condensed N-Heterocyclic Compounds and their Use as CRF Receptor Antagonists |
| 07/14/2011 | US20110172250 Isotopically enriched pyrimidin-5-yl acetic acid derivatives as crth2 antagonists |
| 07/14/2011 | US20110172235 Substituted triazolophthalazine derivatives |
| 07/14/2011 | US20110172228 Kinase inhibitors and methods of use |
| 07/14/2011 | US20110172216 Pyrazolopyrimidine pi3k inhibitor compounds and methods of use |
| 07/14/2011 | US20110168984 Visible/near-infrared porphyrin-tape/c60 organicphotodetectors |
| 07/14/2011 | CA2784744A1 Compound |
| 07/13/2011 | EP2343299A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
| 07/13/2011 | EP2343298A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
| 07/13/2011 | EP2343293A1 Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of t-cell proliferation and uses thereof |
| 07/13/2011 | EP2343290A1 Diamine derivatives as factor X inhibitors |
| 07/13/2011 | EP2343285A2 Peptoid compounds |
| 07/13/2011 | EP2342205A1 Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders |